Procedure Revenue -- $31.8 million, reflecting a 13% decline primarily linked to higher clinic attrition and lower procedure volumes. Dietary Supplement Revenue -- Grew 16% to $11.7 million, driven ...
Interest income on the fair value portfolio increased 16% year over year. Fair Value Marks -- No marks recorded in the fourth quarter versus $5 million the prior year; full-year 2025 marks were $6.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results